The technology is being utilized to launch a portfolio of 10+ clinical tests over the next five years to provide decision support for diseases affecting more than 50 million Americans.

ProPharma Group and The Planet Group have reached a definitive agreement to merge the two companies.

AgroSpheres’ AgriCell technology will help deliver the next generation of high-performing, environmentally safe crop protection

BIO-CAT Microbials continues to scale up their probiotic pipeline with their latest microbial strain, Bacillus subtilis BS50.

Internal FDA documents discovered via the Freedom of Information Act indicate a potential FDA bias against health-focused innovation and in favor of industrial corn sweetener producers.

$8 Million Investment to Fund Cutting-Edge Research, Launch Clinical Trials, Create Jobs

Bonumose was selected for its contributions in the fields of nutrition & health.

Late next year, dermatologists will be able to submit a biopsy for genetic analysis and Ampel will then identify the best drugs for treatment.

The research collaboration agreement will further evaluate the Company’s proprietary adenosine analogs as a potential treatment for inflammatory diseases.

AMPEL BioSolutions today announces a breakthrough in precision and personalized medicine that could revolutionize the way doctors treat inflammatory skin diseases.

A Multi-Enzyme Blend Was Tested and Validated in a Newly Adapted In Vitro Digestion Simulation Protocol

This is the company’s 5th FDA Clearance expanding the capabilities of its industry leading VitalStream™ wireless wearable.